Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liewei Wang

Showing results (191-200 of 277) with videos related to

Pageof 28
Sort By:
Steroids|August 28, 2014
Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozoleJames N Ingle, Krishna R Kalari, Aman U Buzdar, et al.
Translational Psychiatry|July 6, 2019
Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatientsSudeepa Bhattacharyya, Ahmed T Ahmed, Matthias Arnold, et al.
NPJ Breast Cancer|September 1, 2017
Breast cancer chemoprevention pharmacogenomics: Deep sequencing and functional genomics of the <i>ZNF423</i> and <i>CTSO</i> genesDuan Liu, Ming-Fen Ho, Daniel J Schaid, et al.
Human Molecular Genetics|February 8, 2017
Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell linesNifang Niu, Tongzheng Liu, Junmei Cairns, et al.
The Journal of Molecular Diagnostics : JMD|January 18, 2022
Targeted Genotyping in Clinical Pharmacogenomics: What Is Missing?Jaime L Lopes, Kimberley Harris, Mary Beth Karow, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|March 15, 2022
Evidence for machine learning guided early prediction of acute outcomes in the treatment of depressed children and adolescents with antidepressantsArjun P Athreya, Jennifer L Vande Voort, Julia Shekunov, et al.
Clinical Pharmacology and Therapeutics|March 15, 2022
Biomarkers for Predicting Abiraterone Treatment Outcome and Selecting Alternative Therapies in Castration-Resistant Prostate CancerSisi Qin, Huanyao Gao, Wootae Kim, et al.
Molecular Cancer|January 16, 2024
Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancerHeba Alkhatib, Jason Conage-Pough, Sangita Roy Chowdhury, et al.
Research Square|June 19, 2023
Syk-dependent alternative homologous recombination activation promotes cancer resistance to DNA targeted therapyQin Zhou, Xinyi Tu, Xiaonan Hou, et al.
Translational Psychiatry|October 8, 2021
Multi-omics driven predictions of response to acute phase combination antidepressant therapy: a machine learning approach with cross-trial replicationJeremiah B Joyce, Caroline W Grant, Duan Liu, et al.
Pageof 28

Showing results (191-200 of 277) with videos related to

Sort By:
Pageof 28
Steroids|August 28, 2014
Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozoleJames N Ingle, Krishna R Kalari, Aman U Buzdar, et al.
Translational Psychiatry|July 6, 2019
Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatientsSudeepa Bhattacharyya, Ahmed T Ahmed, Matthias Arnold, et al.
NPJ Breast Cancer|September 1, 2017
Breast cancer chemoprevention pharmacogenomics: Deep sequencing and functional genomics of the <i>ZNF423</i> and <i>CTSO</i> genesDuan Liu, Ming-Fen Ho, Daniel J Schaid, et al.
Human Molecular Genetics|February 8, 2017
Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell linesNifang Niu, Tongzheng Liu, Junmei Cairns, et al.
The Journal of Molecular Diagnostics : JMD|January 18, 2022
Targeted Genotyping in Clinical Pharmacogenomics: What Is Missing?Jaime L Lopes, Kimberley Harris, Mary Beth Karow, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|March 15, 2022
Evidence for machine learning guided early prediction of acute outcomes in the treatment of depressed children and adolescents with antidepressantsArjun P Athreya, Jennifer L Vande Voort, Julia Shekunov, et al.
Clinical Pharmacology and Therapeutics|March 15, 2022
Biomarkers for Predicting Abiraterone Treatment Outcome and Selecting Alternative Therapies in Castration-Resistant Prostate CancerSisi Qin, Huanyao Gao, Wootae Kim, et al.
Molecular Cancer|January 16, 2024
Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancerHeba Alkhatib, Jason Conage-Pough, Sangita Roy Chowdhury, et al.
Research Square|June 19, 2023
Syk-dependent alternative homologous recombination activation promotes cancer resistance to DNA targeted therapyQin Zhou, Xinyi Tu, Xiaonan Hou, et al.
Translational Psychiatry|October 8, 2021
Multi-omics driven predictions of response to acute phase combination antidepressant therapy: a machine learning approach with cross-trial replicationJeremiah B Joyce, Caroline W Grant, Duan Liu, et al.
Pageof 28